Yongqiang Yang

6PUBLICATIONS
16CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 13, 2026
Continuation of First-Line Systemic Therapy with Progression-Directed Radiotherapy in Patients with Oligoprogressive Hepatocellular Carcinoma: A Multicenter, Single-Arm, Phase II Trial.

|Dec 07, 2025
SNRPA upregulation promotes mitochondrial function and drives CRPC aggressiveness.

Xiao-Long Liu, Lu Jin, Yong-Qiang Yang

|Oct 15, 2020
The prognostic value of the lymph node ratio for local advanced gastric cancer patients with intensity-modulated radiation therapy and concurrent chemotherapy after radical gastrectomy in China.

Yongqiang Yang, Yifu Ma, Xiaoyong Xiang

|Sep 12, 2020
LIN28B-AS1-IGF2BP1 binding promotes hepatocellular carcinoma cell progression.

Jian Zhang, Kewei Hu, Yong-Qiang Yang

|May 07, 2020
I-BET726 suppresses human skin squamous cell carcinoma cell growth in vitro and in vivo.

Zhengjun Liu, Ping Li, Yong-Qiang Yang

|Feb 27, 2019
Preoperative Volumetric Modulated Arc Therapy With Simultaneous Integrated Boost for Locally Advanced Distal Rectal Cancer.

Yongqiang Yang, Qiteng Liu, Baoqing Jia

Pageof 1

Frequent Collaborators

1 joint publications

Hailei Guo

1 joint publications

Xiao-Long Liu

1 joint publications

Mei-Hua Lu

1 joint publications

Bo-Xin Xue